World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
15452
World Ranking
2604
National Ranking
102

Andrea Anichini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andrea Anichini sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 269 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Andrea Anichini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrea Anichini sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Andrea Anichini is affiliated with Vita-Salute San Raffaele University in Italy. Their research spans mainly the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, and Cancer Research.

Their work focuses on topics including Cancer Immunotherapy and Biomarkers, Epigenetics and DNA Methylation, Immunotherapy and Immune Responses, Immune cells in cancer, CAR-T cell therapy research, Protein Degradation and Inhibitors, and Histone Deacetylase Inhibitors Research.

Notable recent publications by Andrea Anichini include:

  • Immune Escape Mechanisms in Non Small Cell Lung Cancer, 2020, Cancers

Frequent coauthors collaborating with Andrea Anichini are:

  • Roberta Mortarini
  • Michele Maio
  • Michele Ceccarelli
  • Alessia Covre
  • Francesco Sgambelluri

Andrea Anichini's research has appeared in various publication venues, with multiple articles published in the following journals:

  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancers
  • Journal of Experimental & Clinical Cancer Research
  • Cancer Research

Best Publications

  • Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

    Giovanni Germano;Roberta Frapolli;Cristina Belgiovine;Achille Anselmo

  • Interleukin-12: biological properties and clinical application.

    Michele Del Vecchio;Emilio Bajetta;Stefania Canova;Michael T. Lotze

  • Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

    Giorgio Parmiani;Chiara Castelli;Piero Dalerba;Roberta Mortarini

  • Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

    Giuseppe Lo Russo;Massimo Moro;Michele Sommariva;Valeria Cancila

  • NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo

    Tadepally Lakshmikanth;Shannon Burke;Talib Hassan Ali;Silvia Kimpfler

  • Immunity to cancer: attack and escape in T lymphocyte–tumor cell interaction

    Licia Rivoltini;Matteo Carrabba;Veronica Huber;Chiara Castelli

  • Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy.

    S. Siena;M. Di Nicola;M. Bregni;R. Mortarini

  • An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions

    A Anichini;A Molla;R Mortarini;G Tragni

  • Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients

    Andrea Anichini;Cristina Maccalli;Roberta Mortarini;Stefania Salvi

  • Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.

    Roberta Mortarini;Adriano Piris;Andrea Maurichi;Alessandra Molla

  • Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma.

    E Bajetta;M Del Vecchio;R Mortarini;R Nadeau

  • Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage

    Raffaella Lupetti;Patrizia Pisarra;Alessandro Verrecchia;Cinthia Farina

  • Targeting Heat Shock Proteins on Cancer Cells: Selection, Characterization, and Cell-Penetrating Properties of a Peptidic GRP78 Ligand†

    Youngsoo Kim;Antonietta M. Lillo;Sebastian C J Steiniger;Ying Liu

  • Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells

    Eric Yvon;Michele Del Vecchio;Barbara Savoldo;Valentina Hoyos

  • Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients.

    Lorena Passoni;Luca Longo;Paola Collini;Addolorata Maria Luce Coluccia

  • The alpha 3 beta 1 integrin is involved in melanoma cell migration and invasion.

    Antonella Melchiori;Roberta Mortarini;Sebastiano Carlone;Pier Carlo Marchisio

  • Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma.

    Andrea Anichini;Roberta Mortarini;Cristina Maccalli;Paola Squarcina

  • Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases.

    Angela Garofalo;Renato G. S. Chirivi;Chiara Foglieni;Rod Pigott

  • Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase

    Marialuisa Sensi;Mara Catani;Giancarlo Castellano;Gabriella Nicolini

  • Immune Escape Mechanisms in Non Small Cell Lung Cancer.

    Andrea Anichini;Valentina E. Perotti;Francesco Sgambelluri;Roberta Mortarini

  • Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study

    Massimo Di Nicola;Roberta Zappasodi;Carmelo Carlo-Stella;Roberta Mortarini

  • Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.

    Marialuisa Sensi;Andrea Anichini

Frequent Co-Authors

Giorgio Parmiani
Giorgio Parmiani University of Siena
Chiara Castelli
Chiara Castelli University of Milan
Silvana Canevari
Silvana Canevari University of Milan
Licia Rivoltini
Licia Rivoltini Fondazione IRCCS Istituto Nazionale dei Tumori
Soldano Ferrone
Soldano Ferrone Harvard University
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University
Giancarlo Pruneri
Giancarlo Pruneri University of Milan
Silvana Pilotti
Silvana Pilotti University of Milan
Luigi Mariani
Luigi Mariani University Hospital of Basel

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to a variety of healthcare careers, many of which benefit from specialized nursing qualifications. For those without a nursing background, exploring online absn programs for non nurses can be an excellent starting point to quickly gain nursing credentials while building a strong foundation in patient care.

If you're seeking a smoother entry into nursing, identifying the easiest absn program to get into is crucial. These programs typically balance flexibility with comprehensive education, enabling students to transition into clinical roles effectively.

For those considering shorter-term practical nursing roles, researching the best easiest lpn programs to get into can help identify pathways that offer prompt entry into the nursing workforce while gaining valuable patient care experience.

Advanced practice roles, like becoming a Family Nurse Practitioner, are also attainable through programs known as the easiest fnp program. These programs provide the clinical expertise and leadership skills necessary to impact immunology-related healthcare delivery at a higher level.

Best Scientists Citing Andrea Anichini

Trending Scientists

Recently Published Articles